Structure−Activity Relationships of 2‘-Fluoro-2‘,3‘-unsaturated d-Nucleosides as Anti-HIV-1 Agents
- 9 February 2002
- journal article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 45 (6) , 1313-1320
- https://doi.org/10.1021/jm010418n
Abstract
We studied the structure−activity relationships of a series of 2‘-fluoro-2‘,3‘-unsaturated d-nucleosides against HIV-1 in human peripheral blood mononuclear (PBM) cells. The target compounds 10−21 and 28−33 were prepared by N-glycosylation of the acetate 4, which was readily prepared from 2,3-O-isopropylidene-d-glyceraldehyde in five steps. Among the newly synthesized nucleosides, 2-amino-6-chloropurine (11), adenine (14), inosine (16), guanine (18), 2,6-diaminopurine (20), and 5-fluorocytosine (30) derivatives were found to exhibit interesting anti-HIV activities with EC50 values of 4.3, 0.44, 1.0, 2.6, 3.0, and 0.82 μM, respectively. The implications for drug resistance of the titled nucleosides with respect to lamivudine-resistant variants (M184V) were also examined, and no significant cross-resistance with the variants was observed with the d-series.Keywords
This publication has 25 references indexed in Scilit:
- In search of a selective antiviral chemotherapyClinical Microbiology Reviews, 1997
- Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral TherapyNew England Journal of Medicine, 1997
- Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture.Proceedings of the National Academy of Sciences, 1991
- Resistance to ddI and Sensitivity to AZT Induced by a Mutation in HIV-1 Reverse TranscriptaseScience, 1991
- Once-Daily Administration of 2′,3′-Dideoxyinosine (ddI) in Patients with the Acquired Immunodeficiency Syndrome or AIDS-Related ComplexNew England Journal of Medicine, 1990
- Comparison of in vitro biological properties and mouse toxicities of three thymidine analogs active against human immunodeficiency virusAntimicrobial Agents and Chemotherapy, 1990
- In Vivo Activity Against HIV and Favorable Toxicity Profile of 2′,3′-DideoxyinosineScience, 1989
- HIV with Reduced Sensitivity to Zidovudine (AZT) Isolated During Prolonged TherapyScience, 1989
- The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- Broad spectrum antiretroviral activity of 2',3'-dideoxynucleosides.Proceedings of the National Academy of Sciences, 1987